SCHEMBL2494093

SCHEMBL2494093

COc1ccccc1C1(CC(=O)N2CCN(c3cnccn3)CC2)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 3/20 0.44
ADAMTS5 Q9UNA0 3/20 0.44
MMP13 P45452 2/20 0.44
LMNA P02545 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 4/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MMP2 P08253 2/20 0.42
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
POLB P06746 1/20 0.40
HTR4 Q13639 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2496303 0.91 KDM4E (0.54) ADAM17ADAMTS5MMP13LMNAL3MBTL1
SCHEMBL2492747 0.88 ADAMTS5 (0.50) ADAM17ADAMTS5MMP13MMP2TSHR
SCHEMBL2493671 0.88 KDM4E (0.49) ADAM17ADAMTS5MMP13LMNAL3MBTL1
SCHEMBL2499319 0.87 ADAM17 (0.50) ADAM17ADAMTS5MMP13LMNACYP1A2
SCHEMBL2498584 0.87 ADAM17 (0.45) ADAM17ADAMTS5MMP13LMNAKDM4E
SCHEMBL2499269 0.84 ADAM17 (0.44) ADAM17ADAMTS5MMP13LMNAKDM4E
SCHEMBL2492641 0.82 TP53 (0.44) ADAM17ADAMTS5MMP13LMNAMMP2
SCHEMBL5674476 0.81 HTR7 (0.45) ADAM17ADAMTS5MMP13LMNAALDH1A1
SCHEMBL5675399 0.79 ADAMTS5 (0.41) ADAM17ADAMTS5MMP13LMNACYP1A2
SCHEMBL2496707 0.77 KDM4E (0.54) ADAM17ADAMTS5MMP13LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 ADAM17 412/4885ADAMTS5 1111/4885MMP13 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.